A cute little brown bear cub in a meadow

(Getty Images)

Stocks dip in widespread pullback

The S&P 500 fell 0.4%, the Nasdaq 100 gave back 0.3%, and the Russell 2000 was at the bottom of the pack with a decline of about 1%.

Nia Warfield, Luke Kawa

8/25/25 3:42PM

After stocks ended last week with their best day in months, they took a breather today, ending near session lows.

The S&P 500 fell 0.4%, the Nasdaq 100 gave back 0.3%, and the Russell 2000 was at the bottom of the pack with a decline of about 1%.

Within the S&P 500, there were 299 more losers than gainers, the most broadly negative day in over a month.

Defensive pockets of the stock market were among the hardest hit, with consumer staples, healthcare, and utilities S&P sector ETFs all down more than 1%.

Seagate was among the day’s bright spots, up about 3% after Cantor Fitzgerald reiterated its “buy” rating on the chipmaker and stuck a $175 price target on the stock. Meanwhile, Keurig Dr Pepper shares tumbled 11% after announcing an $18 billion acquisition and a planned split-up of its coffee business from other drinks. Elsewhere…

Home goods retailers Wayfair, RH, and Williams-Sonoma all dipped lower following President Trump’s Friday post on Truth Social threatening to impose tariffs on US furniture imports.

CSX shares fell 5.2% after Warren Buffett told CNBC that his railroad, BNSF, would not acquire the company, following months of buyout rumors.

American Eagle slid 2.6% after Bank of America downgraded the stock and cut its price target, warning that the retailer’s Sydney Sweeney boost won’t be enough to offset tariffs.

Canadian cannabis companies Tilray, Canopy Growth, and SNDL rallied as momentum around cannabis rescheduling picks up.

Nvidia shares were up as much as 2% before finishing the day up 1% after the chipmaker formally unveiled the Jetson Thor, a platform for physical AI and robotics that it calls a “robot brain.”

Rocket Lab rose 6.4% after the aerospace manufacturer announced plans Friday to expand its US manufacturing base to produce parts for sensitive national-security-related missions.

Roblox closed up 6.2% following a weekend that reportedly saw more than 45 million concurrent players on the popular gaming platform, a record.

Aehr Test Systems soared 35.6% after the semiconductor testing equipment maker said a major hyperscaler has ordered even more of its systems to appraise their AI processors.

Luke Kawa

45m

Broadcom’s post-earnings romp continues on heavy volumes

As Broadcom enjoys a rush of new orders from a major new customer (reported to be OpenAI), it’s also reveling in a flood of traffic into the stock.

Volumes are running at 2.5 times their daily average through 1:20 p.m. ET as traders continue to bid up shares in response to the brighter outlook for 2026 revenues, which sent the stock up 9.4% on Friday.

The chip designer is basking in a flood of price target hikes from Wall Street, with Bank of America, JPMorgan, Argus Research, Citigroup, Bernstein, Deutsche Bank, Morgan Stanley, Barclays, Piper Sandler, Rosenblatt Securities, Wells Fargo, and Susquehanna upping their view on how high shares can go since the company reported earnings last week.

Separately, Taiwanese industry outlet DigiTimes is reporting that orders from several other leading tech companies for custom-made Broadcom chips (or ASICs) are “already in the pipeline.” This report has not been corroborated by our own or any other publication’s reporting to date.

Matt Phillips

SpaceX spectrum deal sends would-be rivals lower

Shares of struggling satellite services company EchoStar soared Monday, after the company — which had recently tottered close to bankruptcy — announced the sale of some of its wireless spectrum licenses to Tesla CEO Elon Musk’s SpaceX for $17 million.

The sale provides a competitive advantage to Musk’s growing Starlink satellite services business, as the licenses it is acquiring from Echostar allows Starlink to operate ground based broadband and cellphone services, the Wall Street Journal reported.

Entities that stood to be hurt by the emergence of a Musk-led SpaceX Starlink service got hit hard on the news. AST SpaceMobile, which has plans to offer a similar satellite-to-consumer cellular service, tumbled.

So did wireless tower providers like Crown Castle and American Tower. Low cost cellular service provider T-Mobile, which had a deal with SpaceX, also slumped, as Luke noted earlier, along with other large wireless telecommunication services providers.

The wireless telecommunications industry grouping within the S&P 500 was down more than 2.5% shortly after noon, making it the worst performing industry within the S&P 500 on Monday.

SpaceX strikes $17B deal to buy EchoStar's spectrum for Starlink's direct-to-phone service | TechCrunch

The wireless telecommunications industry grouping within the S&P 500 was down more than 2.5% shortly after noon, making it the worst performing industry within the S&P 500 on Monday.

Robinhood, Amcor, Applovin surge on after being added to S&P 500

Robinhood, AppLovin vault higher as the "inclusion effect" is in full force

Membership has its privileges.

Matt Phillips4h

J. Edward Moreno

Hims rises, Novo dips after FDA releases “green list” of GLP-1 raw material suppliers

Hims & Hers rose and Novo Nordisk slipped in early trading after the US Food and Drug Administration released a "green list" of foreign GLP-1 ingredient suppliers that it considers in compliance with agency standards.

Some telehealth companies like Hims sell copycat versions of Novo's and Eli Lilly’s blockbuster weight-loss drugs through compounding pharmacies, which take the active ingredients from FDA-approved medications and make adjusted, or "personalized,” versions of the drug for patients.

Novo and Lilly have fought against this, arguing that it infringes on their intellectual property. They've sued smaller telehealth providers, pharmacies, and clinics in lieu of any action against them from the FDA. Instead, the FDA gave compounders a list of suppliers it deems safe.

Recent developments in the cases filed by the drugmakers so far as well as the FDA's recent actions suggest telehealth companies may be in a less risky position than investors previously thought. As of Monday morning, prediction markets pegged the likelihood of a suit from Novo against Hims at 34%, down from about 70% earlier this month.

Luke Kawa

Gold is outperforming the Nasdaq 100 since the launch of ChatGPT

There’s a bull market in anti-humanity.